SMSMED — Scandinavian Medical Solutions A/S Income Statement
0.000.00%
Last trade - 00:00- DKK206.26m
- DKK226.95m
- DKK191.19m
- 25
- 50
- 19
- 20
Annual income statement for Scandinavian Medical Solutions A/S, fiscal year end - September 30th, DKK millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | DAS | DAS | DAS | DAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 41.9 | 71.6 | 111 | 191 |
| Cost of Revenue | ||||
| Gross Profit | 9.23 | 17.3 | 30.1 | 49.4 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 36 | 60.8 | 95.8 | 175 |
| Operating Profit | 5.96 | 10.9 | 14.7 | 16.6 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | 5.82 | 10.5 | 14.7 | 15.8 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 4.51 | 8.16 | 11.4 | 12.2 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 4.51 | 8.16 | 11.4 | 12.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 4.51 | 8.16 | 11.4 | 12.2 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.166 | 0.299 | 0.426 | 0.448 |
| Dividends per Share |